by James Smith | Jun 28, 2016
This post was authored by Kelvin Ng and James Smith. Completing his PhD this year in the Karp lab at MIT/Harvard, Kelvin focuses on strategies and technologies that guide or accelerate the translation of therapeutic extracellular vesicles. His multidisciplinary...
by David Kent | Jun 24, 2016
The 2016 Annual Meeting of the International Society for Stem Cell Research got off to a fantastic start Wednesday night in San Francisco. Two excellent sessions were delivered to a packed house with talks ranging from the importance of circular RNAs (Pier Paolo...
by Mark Curtis | Jun 23, 2016
Welcome to your deal review for the month of May. Intellia Therapeutics went public this past month giving investors a second shot on net if they want to gain exposure to gene editing technologies. Caladrius Biosciences spun-out its cell-based immunotherapy to AiVita...
by Samantha Payne | Jun 20, 2016
This post is the second of two covering the World Biomaterials Congress. To read my previous blog about the use of biomaterials to study cell behaviour and differentiation in vitro, please click here. This post will cover the use of biomaterials for in vivo delivery...
by Alanna Evans | Jun 17, 2016
Peanut butter and jelly. Macaroni and cheese. Fish and chips. Some things are just better paired together. But there’s one combination you’d never expect to see: surrogate rhinos and stem cells. With just three northern white rhinos left on earth, it looks like...
by Jovana Drinjakovic | Jun 13, 2016
When Dr. Andras Nagy, a Senior Scientist at Sinai Health System’s Lunenfeld-Tanenbaum Research Institute in Toronto, set out to catalogue molecular events behind reprogramming — a process of making stem cells in a dish — he did not expect to uncover a new kind...
by Stacey Johnson | Jun 10, 2016
In 2002, Jennifer Molson received a stem cell transplant for her aggressive form of multiple sclerosis (MS), diagnosed six years earlier when she was 21. This unique treatment for MS – transplanting blood stem cells from a patient’s own bone marrow to replace the...
by Samantha Payne | Jun 7, 2016
The World Biomaterials Congress (WBC), which takes place once every four years, happened last month. Among the many excellent presentations at WBC, two themes related to cell-based therapies stood out: 1) the use of biomaterials to study cell behaviour and...
by Stacey Johnson | Jun 3, 2016
Have you ever wanted to shed your skin? I don’t mean in the metaphorical sense like becoming a different person, free of all the old baggage we accumulate in life. And I’m not talking about CCRM’s new logo and colours either, but thanks for noticing. (Shameless.) I...
by David Kent | May 31, 2016
Throughout the last decade, I have undertaken research in the stem cell field in two countries (Canada and the United Kingdom) and while my work has never involved the ethically contentious human embryonic stem (ES) cell lines, I have interacted with dozens of...
Comments